דוטאסטמד - Dutastamed

× ×ª×× × ×ª×¨××¤×

××¦××ª

××××¢ × ××¡×£

×¡×¨××× ××

××¨×¦×××ª

××××¨××

××¦×¤××× ×××××¢ ×××¨×× ××¨××¤××× ××© ××××× ×¡ ×××©××× ×. ×× ××× × ×¨×©×× ××× ×¡ ×××¨×©×× ××¨××¤××× ××× ×©× ××§×¦××¢××ª ×¨×¤×××××.

××©×¤×¢×ª ××ª× ×××¡×××××× ××¤× × × ××ª×× ××¨××ª×ª ×¨×× ×¢× ×ª××¦××× ××ª×¨ × ××ª×××××

× ×ª×× × ×ª×¨××¤×

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)	G04CA Alpha-adrenoreceptor antagonists G04CB Testosterone-5-alpha reductase inhibitors
××¨××× ×¤×¢×× (ATC5)	Â Dutasteride 0.5 MG âG04CB02 Tamsulosin hydrochloride 0.4 MG âG04CA02
×¦××¨×ª ××ª×	×¤××× - PER OS
×¦××¨×ª ××× ××	×§×¤×¡××× ×§×©×××, HARD CAPSULE ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH). Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	××× ×¢××× ××¨××¤× Â

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 05.05.2021 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 05.05.2021 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 05.05.2021

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××××¡××× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	AUROBINDO PHARMA LTD., INDIA
×©× ××¢× ××¨××©××	INOVAMED PHARMA LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 5/2020. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	{{{×ª××¨×× ×¢××××}}}

השינוי האחרון נעשה בֹ־15 ביוני 2025 ב־15:50